Delayed diagnosis in children with congenital heart disease: a mixed-method study

Indah K Murni1, Muhammad Taufik Wirawan2, Linda Patmasari2

  • 1Department of Child Health, Dr. Sardjito Hospital / Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Jalan Kesehatan No 1, Sekip, Yogyakarta, 55281, Indonesia. indah.kartika.m@ugm.ac.id.

BMC Pediatrics
|April 22, 2021
PubMed

Insights

Six in ten children experienced delayed diagnosis of congenital heart disease (CHD). Delayed diagnosis by doctors was the primary cause, particularly in cyanotic CHD cases, highlighting critical areas for intervention.

Area of Science:

  • Pediatrics
  • Cardiology
  • Public Health

Background:

  • Delayed diagnosis of congenital heart disease (CHD) leads to increased morbidity and mortality.
  • Early detection is crucial for improving outcomes in pediatric cardiac patients.

Purpose of the Study:

  • To determine the proportion of delayed diagnoses in children with CHD.
  • To identify factors associated with delayed CHD diagnosis.

Main Methods:

  • A prospective, mixed-methods cohort study was conducted.
  • Included were 838 children (<18 years) with newly diagnosed, echocardiography-confirmed CHD.
  • Data collected via medical records and caregiver interviews; logistic regression identified associated factors.

Main Results:

  • 60.8% of all children with CHD faced delayed diagnosis, with higher rates in cyanotic CHD (86.2%).
  • Common causes included diagnostic delays by doctors, midwifery care, financial, and referral issues.
  • Factors independently associated with delay were cyanotic CHD, rural residence, non-syndromic cases, low income, normal birth, and term gestation.

Conclusions:

  • Significant delays in CHD diagnosis are prevalent, affecting six in ten children.
  • Doctor-related delays are most common, emphasizing the need for improved clinical awareness and diagnostic pathways.
  • Cyanotic CHD, socioeconomic factors, and geographical location significantly impact diagnostic timeliness, necessitating targeted interventions.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
194
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
69
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
68
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
119